Through in vivo and in vitro experiments, researchers discovered that FABP7 can promote HER2 + breast cancer cells adaptation to the brain microenvironment by supporting the glycolytic phenotype and lipid droplet storage [99]. The gene discussed is ERBB2; the disease is breast carcinoma.